Adalimumab (Humira®) is effective in treating patients with psoriatic arthritis (PSA) in real-life clinical practice:: Results of the stereo trial

被引：0
|
作者：
van den Bosch, F. [1 ]
Manger, B. [2 ]
Goupille, P. [3 ]
McHugh, N. [4 ]
Roedevand, E. [5 ]
Holck, P. [6 ]
van Vollenhoven, R. [7 ]
Leirisalo-Repo, M. [8 ]
FitzGerald, O. [9 ]
Frank, C. [10 ]
Kron, M. [10 ]
Frank, M. [10 ]
Kupper, H. [10 ]
机构：
[1] State Univ Ghent Hosp, B-9000 Ghent, Belgium
[2] Univ Erlangen Nurnberg, Erlangen, Germany
[3] Univ Hosp, Tours, France
[4] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England
[5] St Olavs Hosp, Trondheim, Norway
[6] Silkeborg Centralsygehus, Silkeborg, Denmark
[7] Karolinska Univ Hosp, Stockholm, Sweden
[8] Univ Helsinki, Cent Hosp, Helsinki, Finland
[9] St Vincents Univ Hosp, Dublin, Ireland
[10] Abbott GmbH & Co KG, Ludwigshafen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [1] Adalimumab (HUMIRA®) is effective and safe in treating psoriatic arthritis (PsA) in real-life clinical practice:: Preliminary results of the STEREO trial.
    Van den Bosch, F.
    Reece, R.
    Manger, B.
    Goupille, P.
    Roedevand, E.
    Holck, P.
    FitzGerald, O.
    Van Vollenhoven, R.
    Leirisalo-Repo, M.
    Kron, M.
    Frank, M.
    Kupper, H.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S719 - S720
  • [2] Treatment with adalimumab (Humira®) is safe and effective in psoriatic arthritis (PsA) patients in real-life clinical practice:: Preliminary results of the stereo trial
    Vandenbosch, F.
    McHugh, N. J.
    Reece, R.
    Cooper, R.
    Manger, B.
    Goupille, P.
    FitzGerald, O.
    Kron, M.
    Frank, M.
    Kupper, H.
    Roedevand, E.
    Holck, P.
    VanVollenhoven, R.
    Leirisalo-Repo, M.
    RHEUMATOLOGY, 2007, 46 : I52 - I53
  • [3] Efficacy of adalimumab in psoriatic arthritis (PsA) in real-life clinical practice: Preliminary results of STEREO
    Van den Bosch, Filip
    Manger, Bernhard
    Frank, Martina
    Kupper, Hartmut
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB184 - AB184
  • [4] Clinical remission in patients with psoriatic arthritis (PsA) treated with adalimumab (humira®). results of the stereo trial
    Van den Bosch, F.
    Manger, B.
    Goupille, P.
    McHugh, N.
    Kron, M.
    Kary, S.
    Kupper, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 743 - 743
  • [5] Clinical remission and good clinical responses in patients with psoriatic arthritis (PsA) treated with adalimumab (HUMIRA®):: Results of the STEREO trial
    Van den Bosch, Filip
    Manger, Bernhard
    Goupille, Philippe
    Kron, Martina
    Kary, Sonja
    Kupper, Hartmut
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S576 - S576
  • [6] Adalimumab treatment is effective in patients with psoriatic arthritis (PSA) in day-to-day clinical practice - Results from the stereo trial
    McHugh, N.
    van den Bosch, Filip
    Manger, B.
    Goupille, P.
    Cooper, R.
    Kron, M.
    Kupper, Hartmut
    RHEUMATOLOGY, 2008, 47 : II76 - II76
  • [7] Adalimumab (Humira®) is effective and safe in treating rheumatoid arthritis (RA) in real-life clinical practice:: Final summary of the 6610 patients in the react study
    Burmester, G. R.
    Saez, I. Monteaguclo
    Fardellone, P.
    Montecucco, C. M.
    Nash, P.
    Katy, S.
    Kupper, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 181 - 181
  • [8] Adalimumab (HUMIRA®) is effective and safe in treating rheumatoid arthritis (RA) in real-life clinical practice:: 1-year-results of the ReAct study.
    Burmester, GR
    Sáez, IM
    Malaise, MG
    Kary, S
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S541 - S542
  • [9] Adalimumab (HUMIRA®) is effective and well-tolerated in combination with traditional DMARDs in treating rheumatoid arthritis in real-life clinical practice.
    Ivorra, J. A. Román
    Valesini, G.
    Bijlsma, J. W. J.
    Unnebrink, K.
    Oezer, U.
    Kupper, H.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S404 - S404
  • [10] Adalimumab (HUMIRA®) is effective in treating patients with rheumatoid arthritis who previously failed etanercept and/or infliximab in real-life clinical settings.
    Bombardieri, S
    Tzioufas, AG
    McKenna, F
    Özer, Ü
    Kupper, H
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S144 - S144
12345